At two or more years after starting treatment, the odds of a new diagnosis of alopecia in GLP-1 users were 37% higher than in users of so-called SGLT-2 drugs and 68% higher versus DPP-4 drugs, researchers at the University of Pennsylvania reported Wednesday in The BMJ
Similarly, the other big metabolic issue of the day is insulin resistance, slash, ultimately becoming diabetic
Colorados Attorney General joined a lawsuit with 36 other states earlier this year, urging the FDA to enforce regulations surrounding compounded GLP-1s as well as cracking down on counterfeit versions of the drug
Some individuals may experience mild adverse effects such as nausea, diarrhea, stomach cramps, or muscle weakness
Whether youre managing diabetes, improving heart health, or pursuing sustainable weight goals, remember that wellness is a journey